At acute and convalescent phases, plasma MPO activity were significantly higher in COVID-19 subjects compared with controls [controls, median (IQR); 36.99 (34.80–39.01) unit/ml, acute (p < 0.01); convalescent (p < 0.001)]. Here, MPO is linked to COVID-19.